Pharmaceutical Patents in Europe: Radical Reforms Rather Than Getting Rid? Livio GarattiniBruno Finazzi Editorial 29 November 2021 Pages: 453 - 455
Data-Related Challenges in Cost-Effectiveness Analyses of Vaccines Jamison PikeAndrew J. LeidnerScott D. Grosse Practical Application 09 February 2022 Pages: 457 - 465
Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version Eun-Young BaeJihyung HongTae-jin Lee Leading Article 11 March 2022 Pages: 467 - 477
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy Nadine T. HillockTracy L. MerlinJonathan Karnon Review Article Open access 04 April 2022 Pages: 479 - 486
A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis Edyta RyczekSusan C. PeirceSian Lewis Review Article Open access 25 February 2022 Pages: 487 - 499
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options Rositsa Koleva-KolarovaJames BuchananThe HEcoPerMed Consortium Systematic Review Open access 04 April 2022 Pages: 501 - 524
What Policy Approaches Were Effective in Reducing Catastrophic Health Expenditure? A Systematic Review of Studies from Multiple Countries HyunWoo JungKwang-Soo Lee Systematic Review 14 March 2022 Pages: 525 - 541
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting Sara StaffordPeter G. BechAiden Liu Original Research Article Open access 28 March 2022 Pages: 543 - 555
How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15 Stephen MartinKarl ClaxtonFrancesco Longo Original Research Article 14 March 2022 Pages: 557 - 572
Population Norms for SF-6Dv2 and EQ-5D-5L in China Shitong XieJing WuFeng Xie Original Research Article 08 February 2022 Pages: 573 - 585
Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand Piyameth DilokthornsakulRatree SawangjitUnchalee Permsuwan Original Research Article 10 February 2022 Pages: 587 - 596
Preferred Attributes of Care Pathways for Obstructive Sleep Apnoea from the Perspective of Diagnosed Patients and High-Risk Individuals: A Discrete Choice Experiment Andrea N. NatskyAndrew VakulinBillingsley Kaambwa Original Research Article Open access 10 February 2022 Pages: 597 - 607
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women Nidhi GuptaDharna GuptaShankar Prinja Original Research Article 10 May 2022 Pages: 609 - 621
Correction to: Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting Sara StaffordPeter G. BechAiden Liu Correction Open access 20 April 2022 Pages: 623 - 623
